🔗 Share this article

Chancellor Reeves has revealed she is planning "focused measures to tackle cost of living challenges" in next month's financial statement.

In comments to media outlets, she emphasized that curbing inflation is a collective responsibility of both the administration and the central bank.

The UK's price growth is expected to be the highest among the Group of Seven developed nations this year and next.

Possible Utility Bill Measures

It is understood the government could take action to lower utility costs, for instance by slashing the present 5% level of VAT applied on energy.

An additional possibility is to lower some of the regulatory levies presently added to bills.

Budgetary Limitations and Analyst Expectations

The government will obtain the next report from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will reveal how much scope there is for such measures.

The consensus from most economists is that Reeves will have to announce tax rises or expenditure reductions in order to fulfill her voluntary borrowing rules.

Previously on the same day, analysis showed there was a twenty-two billion pound shortfall for the Treasury chief to fill, which is at the more modest range of forecasts.

"There's a collective task between the central bank and the government to bear down further on some of the causes of price increases," Reeves stated to the BBC in the US capital, at the conferences of the IMF and global financial institution.

Revenue Pledges and International Issues

While a great deal of the focus has been on likely tax rises, the Treasury chief said the most recent data from the OBR had not changed her pledge to campaign commitments not to raise tax levels on earnings tax, VAT or National Insurance.

She blamed an "uncertain world" with rising international and trade tensions for the fiscal revenue measures, probably to be focused on those "wealthiest."

Global Economic Tensions

Referring to apprehensions about the UK's economic relations with China she said: "Our security interests always take priority."

Recent announcement by China to strengthen export controls on critical minerals and other resources that are key for advanced tech manufacturing led US President Donald Trump to threaten an further 100% tariff on goods from China, increasing the risk of an full-scale trade war between the two largest economies.

The American finance chief described China's decision "commercial pressure" and "a global supply chain power grab."

Asked about accepting the US offer to participate in its conflict with the Asian nation, the Chancellor said she was "deeply worried" by China's actions and urged the Beijing authorities "not to put up barriers and limit trade."

She said the action was "harmful for the global economy and generates additional obstacles."

"It is my opinion there are areas where we must address Chinese policies, but there are also significant chances to trade with Chinese markets, including banking sector and other sectors of the economic system. We've got to achieve that equilibrium correct."

The Treasury chief also stated she was cooperating with international partners "regarding our own essential resources strategy, so that we are more independent."

Health Service Medicine Pricing and Investment

The Chancellor also recognized that the price the National Health Service pays for drugs could rise as a result of current negotiations with the Trump administration and its pharmaceutical firms, in return for lower tariffs and funding.

Some of the biggest global pharmaceutical manufacturers have said recently that they are either halting or scrapping operations in the UK, with several blaming the insufficient payments they are getting.

Recently, the Science Minister said the cost the NHS spends on medicines would need to increase to prevent firms and pharmaceutical investment departing from the United Kingdom.

Reeves stated to the BBC: "We have seen because of the pricing regime, that clinical trials, innovative medicines have not been available in the UK in the way that they are in other EU nations."

"Our aim is to guarantee that people receiving care from the NHS are can obtain the top critical medicines in the globe. And so we are looking at these issues, and... seeking to secure additional funding into the UK."